Send to a Friend Font Size: Increase Decrease

OrbiMed Advisors

OrbiMed Advisors's Portfolio

Last Updated on 5/16/11 @ 11:13am

Ticker	# of Shares	Price	Value
	73,114,592	$195.32	$14,280,742,110
	22,362,850	$195.32	$4,367,911,862
	17,233,668	$195.32	$3,366,080,034
	14,567,176	$195.32	$2,845,260,817
	9,033,726	$195.32	$1,764,467,363
	8,998,338	$195.32	$1,757,555,379
	8,322,140	$195.32	$1,625,480,385
	8,009,729	$195.32	$1,564,460,269
	7,619,135	$195.32	$1,488,169,449
View Additional Portfolio Information »

http://www.orbimed.com/OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. The firm was stated in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.

Login to help us fill in information about this entity.

View Older Stories View More Recent Stories

Aug 26, 2021 06:30AM Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders
Aug 25, 2021 08:44PM Form 4 Repare Therapeutics Inc. For: Aug 23 Filed by: ORBIMED ADVISORS LLC
Aug 19, 2021 08:55PM Form 4 Repare Therapeutics Inc. For: Aug 17 Filed by: ORBIMED ADVISORS LLC
Aug 17, 2021 05:59PM Form 4 Xtant Medical Holdings, For: Aug 15 Filed by: ORBIMED ADVISORS LLC
Aug 16, 2021 04:46PM Form SC 13D/A Ikena Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 16, 2021 04:19PM Form 13F-HR ORBIMED ADVISORS LLC For: Jun 30
Aug 12, 2021 04:18PM Form SC 13D/A Oric Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Aug 4, 2021 05:22PM Form SC 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Aug 4, 2021 12:00PM XinThera Closes $50M Series B Financing
Aug 2, 2021 07:00AM Zentera Therapeutics Announces Closing of $75 Million Series B Financing
Aug 2, 2021 07:00AM Zentera Therapeutics Announces Closing of $75 Million Series B Financing
Jul 23, 2021 05:31PM Form 4/A IMARA Inc. For: Jul 16 Filed by: ORBIMED ADVISORS LLC
Jul 21, 2021 05:30PM Form 4 Acutus Medical, Inc. For: Jul 19 Filed by: ORBIMED ADVISORS LLC
Jul 16, 2021 04:28PM Form 4 IMARA Inc. For: Jul 16 Filed by: ORBIMED ADVISORS LLC
Jul 14, 2021 05:09PM Form SC 13D/A Compass Therapeutics, Filed by: ORBIMED ADVISORS LLC
Jul 14, 2021 06:04AM Form SC 13D/A Acutus Medical, Inc. Filed by: ORBIMED ADVISORS LLC
Jul 6, 2021 04:43PM Form 4 SpringWorks Therapeutics For: Jul 01 Filed by: ORBIMED ADVISORS LLC
Jun 30, 2021 09:02PM Form 4 SpringWorks Therapeutics For: Jun 28 Filed by: ORBIMED ADVISORS LLC
Jun 25, 2021 07:12PM Form 4 SpringWorks Therapeutics For: Jun 23 Filed by: ORBIMED ADVISORS LLC
Jun 23, 2021 03:30AM Leukocare Announces USD 17.5 Million Financing Round to Further Expand US Business and Bioinformatics Activities
Jun 22, 2021 06:02AM Form SC 13D Janux Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Jun 15, 2021 11:32AM Frontera Therapeutics Starts GMP Manufacturing Facility Construction
Jun 14, 2021 05:58PM Form 4 SpringWorks Therapeutics For: Jun 10 Filed by: ORBIMED ADVISORS LLC
Jun 9, 2021 06:27PM Form 4 SpringWorks Therapeutics For: Jun 07 Filed by: ORBIMED ADVISORS LLC
May 17, 2021 04:23PM Form 13F-HR ORBIMED ADVISORS LLC For: Mar 31
May 11, 2021 07:00AM Xtant Medical Files $150 Million Shelf Registration Statement
Apr 29, 2021 05:18PM Form SC 13G NeuroPace Inc Filed by: ORBIMED ADVISORS LLC
Apr 26, 2021 05:21PM Form 4 NeuroPace Inc For: Apr 26 Filed by: ORBIMED ADVISORS LLC
Apr 23, 2021 08:33PM Form 4 NeuroPace Inc For: Apr 21 Filed by: ORBIMED ADVISORS LLC
Apr 22, 2021 06:51PM Sinovac Reports Unaudited Fourth Quarter 2020 Financial Results and Files 2020 Annual Report on Form 20-F
Apr 22, 2021 05:19PM Form 4 SYNLOGIC, INC. For: Apr 20 Filed by: ORBIMED ADVISORS LLC
Apr 22, 2021 05:04PM Form SC 13D/A SYNLOGIC, INC. Filed by: ORBIMED ADVISORS LLC
Apr 22, 2021 05:00AM ITM Raises EUR 90 M (USD 109 M) to Accelerate Precision Oncology Pipeline and Support Ongoing Phase 3 Clinical Program
Apr 20, 2021 05:31PM Form 3 NeuroPace Inc For: Apr 20 Filed by: ORBIMED ADVISORS LLC
Apr 20, 2021 04:38PM Form SC 13G VectivBio Holding AG Filed by: ORBIMED ADVISORS LLC
Apr 15, 2021 07:39AM Form SC 13D Ikena Oncology, Inc. Filed by: ORBIMED ADVISORS LLC
Apr 9, 2021 04:36PM Form SC 13D/A Xtant Medical Holdings, Filed by: ORBIMED ADVISORS LLC
Apr 8, 2021 06:01AM Form SC 13D Edgewise Therapeutics, Filed by: ORBIMED ADVISORS LLC
Apr 7, 2021 04:39PM Form SC 13D/A Turning Point Therapeuti Filed by: ORBIMED ADVISORS LLC
Mar 31, 2021 05:09PM Form 4 Oric Pharmaceuticals, For: Mar 29 Filed by: ORBIMED ADVISORS LLC
Mar 31, 2021 10:00AM Scribe Therapeutics Raises $100M Series B Financing to Further Develop “CRISPR by Design” Platform and Pipeline of Breakthrough Genetic Medicines
Mar 29, 2021 04:25PM Form SC 13D/A SYNLOGIC, INC. Filed by: ORBIMED ADVISORS LLC
Mar 29, 2021 07:30AM Crossover Health Secures $168 Million in Series D Financing to Fuel Expansion of National Primary Health Service
Mar 26, 2021 05:52PM Form 4 Oric Pharmaceuticals, For: Mar 24 Filed by: ORBIMED ADVISORS LLC
Mar 26, 2021 05:08PM Form SC 13D/A GRAYBUG VISION, INC. Filed by: ORBIMED ADVISORS LLC
Mar 25, 2021 09:40PM Form 3 Edgewise Therapeutics, For: Mar 25 Filed by: ORBIMED ADVISORS LLC
Mar 25, 2021 08:13PM Form 3 Ikena Oncology, Inc. For: Mar 25 Filed by: ORBIMED ADVISORS LLC
Mar 25, 2021 07:04PM Form SC 13G/A X4 Pharmaceuticals, Inc Filed by: ORBIMED ADVISORS LLC
Mar 24, 2021 12:00PM Lyfebulb and CSL Behring Announce the Finalists for the 2021 Transplant Innovation Challenge
Mar 23, 2021 05:23PM Form 4 Oric Pharmaceuticals, For: Mar 19 Filed by: ORBIMED ADVISORS LLC

View More Recent Stories View Older Stories

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed